Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process.
Clonally expanded mitochondrial DNA deletions within the choroid plexus in multiple sclerosis.
Quantitative proton density mapping: correcting the receiver sensitivity bias via pseudo proton densities.
Is multiple sclerosis a proresolution deficiency disorder?
Mortality statistics for multiple sclerosis and amyotrophic lateral sclerosis in sweden.
Vitamin D Responsive Elements within the HLA-DRB1 Promoter Region in Sardinian Multiple Sclerosis Associated Alleles.
Cyclophosphamide is effective in stabilizing rapidly deteriorating secondary progressive multiple sclerosis.
Anti-integrin therapy for multiple sclerosis.
N-Acetylcysteine amide: A Derivative to Fulfill the Promises of N-Acetylcysteine.
A cross-sectional study examining multiple mobility device use and fall status among middle-aged and older adults with multiple sclerosis.
MiR-30a inhibits Th17 differentiation and demyelination of EAE mice by targeting the IL-21R.
Early Treatment with Anti-VLA-4 mAb Can Prevent the Infiltration and/or Development of Pathogenic CD11b+CD4+ T Cells in the CNS during Progressive EAE.
Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes.
Inflammatory Response and Chemokine Expression in the White Matter Corpus Callosum and Gray Matter Cortex Region During Cuprizone-Induced Demyelination.
Th17 Cells: Biology, Pathogenesis of Autoimmune and Inflammatory Diseases, and Therapeutic Strategies.
The cytokines cardiotrophin-like cytokine/cytokine-like factor-1 (CLC/CLF) and ciliary neurotrophic factor (CNTF) differ in their receptor specificities.
Eosinophilic Fasciitis Occurring under Treatment with Natalizumab for Multiple Sclerosis.
Intractable Nausea and Vomiting from Autoantibodies Against a Brain Water Channel.
Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis.
Evaluation of oxidative and nitrosative stress in relapsing remitting multiple sclerosis: effect of corticosteroid therapy.
In situ expansion of T cells that recognize distinct self-antigens sustains autoimmunity in the CNS.
Evaluation of the 2010 McDonald multiple sclerosis criteria in children with a clinically isolated syndrome.
Autoinflammatory grey matter lesions in humans: cortical encephalitis, clinical disorders, experimental models.
Patterns of Retinal Damage Facilitate Differential Diagnosis between Susac Syndrome and MS.
Comparative analysis of first-year fingolimod and natalizumab drug discontinuation among Swedish patients with multiple sclerosis.

Pages